Hello Atlas Venture Partner

Welcome to Atlas Ventures Partner Portal. Here you will have access to all the newest information and resources catering to your specific needs and interests. Sign in below for instant access.

Sign Here

atlas logo

Drive Your Discovery Research

Discovering and characterizing novel drug candidates for preclinical development depends on innovative and reliable science. Our unique combination of integrated, multidisciplinary drug discovery expertise and unparalleled scope of capabilities in targets, platforms, and therapeutic areas allow us to deliver depth and breadth in science with data and insight you can trust to progress your drug discovery programs.

Discovery Services:

 •   Integrated Drug Discovery
 •   Chemistry
 •   Screening & Profiling Assays
 •   Pharmacology Studies
 •   Discovery Facilities

Photo of syringe in vaccine bottle.

Discovery Services and Facilities

Discovering and characterizing novel drugs depends on innovative and reliable science. Our multidisciplinary drug discovery expertise and scope of capabilities allow us to deliver data and insight clients can trust to progress their drug discovery programs. Browse Our Services

Charles River chemistry, biology, large molecule and small molecule screening scientists deliver patents and compound candidates in many therapeutic areas including oncology, neurology, immune-oncology, pain, inflammation and respiratory to our drug discovery cro clients.

Track Record of Candidates

Check out our preclinical candidate delivery and patent track record by therapeutic area. Will our next discovery be yours?


Catch up on our latest news collections…

 •   Q2 2020: New Regulations for COVID-19 Vaccine Development

 •   Q1 2020: Expanding Digital Resources To Support You

 •   Q4 2019: See How This Little Girl Changed Drug Development Forever

 •   Q3 2019: A Collaborative Breakthrough for Cardiovascular Patients

Quarterly Newsletter

Catch up on our latest news collections…

Photo of syringe in vaccine bottle.

New Regulations for COVID-19 Vaccine Development

International Coalition of Medicines Regulatory Authorities held a meeting for development of a vaccine to fight COVID-19. Their insight can be vital in how you proceed with your program.

Here's a Summary

Clinical Biomarker Lab for PD Biomarker Assay.

Fail Fast, Fail Early

Using pharmacodynamic efficacy biomarkers in earlier stages of testing can lead to lower drug development costs and improve your drug candidate’s chances of progressing beyond Phase II.

Improve Your Chances


Enter a New Era of CNS Drug Discovery

The complexity of the brain and high attrition rates can make neuroscience drug discovery a daunting process, but you don’t have to do it alone.

Try a Different Approach

Upcoming Webinars

Oncologists: What Antibodies Can Do for You | July 13, 2020

Human Dose Predictions in Early Drug Discovery | July 21, 2020

A Molecular Journey to Investigate Memory Enhancement | July 22, 2020

On Demand Webinars

Advanced Mass Spectrometry-Based Characterization of Adeno-Associated Viruses and Next Generation Biologics

A New Translational In Vivo Tool for Oncology Drug Discovery: Zebrafish Tumor Xenograft Model

Bioinformatics: Mining Big Data to Discover Precision Oncology Therapies